A

Achilles Therapeutics (ACHL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Achilles Therapeutics (ACHL)

Achilles Therapeutics PLC provides pharmaceuticals products. The Company offers therapies that target truncal tumour neo-antigens. Achilles Therapeutics serves customers in the United Kingdom.

  • USD0.92
  • USD0.95
  • USD0.90
  • USD3.45
  • -19.10%
  • --
  • 94.17k
  • 244.77k
  • 33M
  • 0.75
  • -70.00%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.